Jolanta Bialkowska

Jolanta Bialkowska

Department Of Infectious And Liver Diseases, Medical University Of Lodz, 90-419 Lodz, Poland;, Jolanta.e.bialkowska@gmail.com

Direct Impact

Concepts for which Jolanta Bialkowska has direct influence:

chronic hepatitis
liver cirrhosis
hepatic decompensation
hepatocellular carcinoma
hcv infection
virologic response
pegylated interferon alpha

External impact

Concepts related to the work of other authors for which Jolanta Bialkowska has influence:

advanced liver
chronic hepatitis
hcv genotype
drug interactions
sustained virologic response
spanish hepa-c
central europe

Prominent publications by Jolanta Bialkowska

KOL-Index: 112 (1) Background: Treatment of hepatitis C virus (HCV) infections with direct-acting antivirals (DAA) has demonstrated high efficacy and an excellent safety profile. The cured patients showed a sustained virological response and improved liver function, but also a continued risk of hepatocellular carcinoma (HCC) during the 2-3 years of follow-up after treatment; (2) Methods: A total of 192 ...
Known for
Daa Stable | Function Improved | Cured Sustained
KOL-Index: 92 BACKGROUND: To evaluate the effectiveness and safety of ledipasvir/sofosbuvir (LDV/SOF)±ribavirin (RBV) regimen in a real-world setting. METHODS: Patients received a fixed-dose combination tablet containing LDV and SOF with or without RBV, for 8, 12 or 24 weeks. Patients were assessed at baseline, end of treatment, and 12 weeks after the end of treatment. The primary effectiveness endpoint ...
Known for
Null-Responders | Hcv Rna | 8-Week Regimen | Effective Safe Option
KOL-Index: 89 The aim of the EpiTer-2 study was to analyse patient characteristics and their medication for HCV infection in Poland at the beginning of the interferon-free era. Analysis of data of HCV infected patients treated during the initial period of availability of interferon-free regimens in Poland, who started therapy after 1 July 2015 and had available an efficacy evaluation report before 30 June ...
Known for
Infection Poland | Current Therapeutic Programme | Introduced Therapeutic Options | Interferon-Free Regimens
KOL-Index: 59 We followed for 2 years patients treated with direct-acting agents (DAA) to assess long-term durability of virologic response, improvement of liver function, reduction in liver stiffness (LS) and risk of hepatocellular carcinoma (HCC). The study included patients from 16 hepatologic centres involved in the AMBER, investigator-initiated study on treatment of chronic hepatitis C patients ...
Known for
Improvement Liver | Response Novo | Decompensation Hcc | Primary Major
KOL-Index: 32 BACKGROUND: Virologic and safety outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin (OBV/PTV/r ± DSV ± RBV) therapy have shown high sustained virologic response (SVR) rates and good tolerability in most patient populations in pre-registration studies. AIM: To confirm these clinical trial findings in the treatment of genotype 1 and 4 hepatitis C under real-world conditions. ...
Known for
Real-World Conditions | 4 Hepatitis | | Virologic Safety
KOL-Index: 27 BACKGROUND: Heart rhythm turbulence (HRT) is a novel tool for evaluation of cardiovascular mortality. Liver cirrhosis is associated with hemodynamic and myocardial disturbances termed cirrhotic cardiomyopathy. In the stable stage of liver cirrhosis, systolic and myocardial dysfunction is correlated with brain natriuretic peptide (BNP). The aim was to evaluate HRT and its correlation with ...
Known for
Parameters Turbulence | Serum Nt-Probnp | 25 Mm | Probnp Decompensated
KOL-Index: 15 Aim of the study: This multicentre study aimed to examine the actual risk for drug-drug interactions in a cohort of Polish patients, and their impact on antiviral therapy. Material and methods: Concomitant medications were analyzed in hepatitis C virus (HCV)-infected patients treated with still valuable therapy with OBV/PTV/r ± DSV ± RBV. An established online tool ...
Known for
Medications Modification | Interactions Comedication | Therapy Obv | Dsv
KOL-Index: 12 Among the numerous complications associated with chronic renal disease both bone and hormonal disturbances have long been recognized. The aim of this study was to assess the relations between bone mineral density, gonadal status and specific markers of bone turnover in haemodialysis (HD) population. MATERIAL AND METHODS: We performed a cross-sectional study involving 40 HD patients: 27 men ...
Known for
Estradiol Women | Bone Hormonal | Fsh Normal | Testosterone Concentrations
KOL-Index: 10 The aim of the study is to analyze treatments available for patients infected with genotype (G) 3 hepatitis C virus (HCV) in Poland at the beginning of the interferon (IFN)-free era and evaluate the efficacy and safety of different therapeutic options administered in a real-world setting. We analyzed data of 198 patients who started antiviral therapy after July 1, 2015, and completed it ...
Known for
Sof-Based | Sustained Virologic Response | Chronic Hcv G3 Infection | Ifn-Free Regimens
KOL-Index: 10 BACKGROUND: Despite advances in antiviral therapy over the past 2 decades, herpes simplex encephalitis (HSE) remains a serious illness with significant risk of morbidity and death. HSE is the most common cause of sporadic viral encephalitis, with a predilection for the temporal lobes and a range of clinical presentations, from aseptic meningitis and fever to a severe rapidly progressive form ...
Known for
Seizures Focal | Fever Mental | Severe Rapidly | Prognosis Hse

Department of Infectious and Liver Diseases, Medical University of Lodz, 90-419 Lodz, Poland;, jolanta.e.bialkowska@gmail.com

https://www.g2.com/products/key-opinion-leaders-kols/reviews https://www.bbb.org/us/fl/doral/profile/data-analytics/key-opinion-leaders-0633-92023858 https://www.trustpilot.com/review/keyopinionleaders.com https://www.yelp.com/biz/key-opinion-leaders-miami


© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172